Results 221 to 230 of about 2,066,357 (322)

Distal femoral morphology as a risk factor for osteoarthritis

open access: yesThe Anatomical Record, EarlyView.
Abstract Osteoarthritis (OA) is a leading cause of disability affecting millions of adults in the United States, commonly resulting in the need for total knee arthroplasty (TKA) to restore mobility and quality of life. This study investigates potential differences in baseline distal femoral shape between individuals who received TKA due to OA and a ...
Haley Horbaly
wiley   +1 more source

Peripherally inserted central catheter line-induced fevers: a case report. [PDF]

open access: yesJ Med Case Rep
Hoff CV   +4 more
europepmc   +1 more source

New partial skeleton of Homo habilis from the upper Burgi Member, Koobi Fora Formation, Ileret, Kenya

open access: yesThe Anatomical Record, EarlyView.
Abstract KNM‐ER 64061 is a partial skeleton from the upper Burgi Member of the Koobi Fora Formation (2.02–2.06 Ma) associated taphonomically and geochemically with a nearly complete mandibular dentition (KNM‐ER 64060) attributed to Homo habilis.
Frederick E. Grine   +8 more
wiley   +1 more source

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

open access: yesArthritis &Rheumatology, EarlyView.
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene Mekinian   +111 more
wiley   +1 more source

Can STAT video review replace operative experience? [PDF]

open access: yesTrauma Surg Acute Care Open
Bishop ES, Benjamin ER.
europepmc   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy